Article
Rs205764 and rs547311 in linc00513 may influence treatment responses in multiple sclerosis patients: A pharmacogenomics Egyptian study.
Frontiers in immunology - 1 Jan 2023
Amin Nada Sherif, Abd El-Aziz Mostafa K, Hamed Mohamed, Moustafa Ramez Reda, El Tayebi Hend M
Abstract excerpt
Background: Multiple sclerosis (MS) is characterized by a complex etiology that is reflected in the lack of consistently predictable treatment responses across patients of seemingly similar characteristics. Approaches to demystify the underlying predictors of aberrant treatment responses have made use of genome-wide association studies (GWAS), with imminent progress made in identifying single nucleotide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.